“Despite the controversy caused by the protestor’s appearance, his presence did seem to attract a larger crowd, and [one of the organizers] said that his arrival was a good thing. ‘I was going to let him stay as long as he wanted to, because once white people see how [a racist] acts, they can just reflect on that and see, ‘Oh, I’m not like that. Oh, I actually might want to help.’ And they might want to push against what his thoughts and what his beliefs are.” - A racist clown rolls through a small Black Lives Matter rally at East Tennessee State University, and because of the inherent drama of a person with a Conf...
Friday, February 29, 2008
BLOGSCAN - Dubious Clinical "Researchers"
On the Clinical Psychology and Psychiatry Blog, two posts (here and here) gave examples of how the physicians pharmaceutical and biotechnology companies hire to implement their clinical trials may not always be qualified or competent to do such work, to put it politely. Despite some egregious conduct by such "researchers," the US Food and Drug Administration (FDA) has been slow to take action against them, and presumably the data they produce may still be used to argue for the advantages or particular drugs.